School personnel information

写真b

NAKAGAWA Shinsaku


Mail Address

Mail Address

Gender

Male

Organization 【 display / non-display

  • 1999.06.01 - 2005.07.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Associate Professor

  • 2005.08.01 - 2012.03.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Professor

  • 2012.04.01 - , Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Professor

  • 2001.04.01 - 2002.03.31, Institute for Molecular and Cellular Biology

  • 2004.11.01 - , The Center for Advanced Medical Engineering and Informatics

Education 【 display / non-display

Kobe Gakuin University Faculty of Pharmaceutical Science  Graduated 1982.03
Kobe Gakuin University Graduate School, Division of Pharmaceutical Sciences  Completed 1984.03
Kobe Gakuin University Graduate School, Division of Food and Medical Sciences  Unfinished 1988.03
Osaka University Graduate School, Division of Pharmaceutical Sciences  1993.09

Research topics 【 display / non-display

  • Pharmaceutical chemistry and drug development sciences-related, Clinical pharmacy-related

  • Pharmaceutical chemistry and drug development sciences-related, Clinical pharmacy-related

 

Academic Papers 【 display / non-display

  • Clinical study of a retinoic acid-loaded microneedle patch for seborrheic keratosis or senile lentigo., Hirobe S, Otsuka R, Iioka H, Quan YS, Kamiyama F, Asada H, Okada N, Nakagawa S.,168:24-27, 2017.01, Papers

  • Coating with spermine-pullulan polymer enhances adenoviral transduction of mesenchymal stem cells., Wan L, Yao X, Faiola F, Liu B, Zhang T, Tabata Y, Mizuguchi H, Nakagawa S, Gao JQ, Zhao RC., Int J Nanomedicine.,11:6763-6769., 2016.12, Papers

  • Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research., Inoo K, Inagaki R, Fujiwara K, Sasawatari S, Kamigaki T, Nakagawa S, Okada N., Mol Ther Oncolytics.,16;3:16024, 2016.11, Papers

  • A Cytolethal Distending Toxin Gene-Based Multiplex PCR Assay for Campylobacter jejuni, C. fetus, C. coli, C. upsaliensis, C. hyointestinalis, and C. lari., Kamei K, Kawabata H, Asakura M, Samosornsuk W, Hinenoya A, Nakagawa S, Yamasaki S., Jpn J Infect Dis. ,69(3):256-8., 2016.05, Papers

  • Analysis of skin permeability and toxicological properties of amorphous silica particles., Matsuo K, Hirobe S, Okada N, Nakagawa S, Biol. Pharm. Bull. ,39(7):1201-5., 2016.04, Papers

display all >>

Books 【 display / non-display

  • Special, A novel gene transfer system using fusogenic liposomes.Progress in Drug Delivery System V, H. Mizugiuchi, T. Nakagawa, M. Nakanishi, S. Imazu, T. Nakanishi, M. Kondoh, S. Nakagawa, T. mayumi, Biomedical Research Foundation, 1996.08

  • Special, TNF-alpha-mediated tumor regression by the direct injection of fusogenic liposomes containing its gene into the artery controlling tumor.Progress in Drug Delivery System V, T. Nakagawa, H. Mizugiuchi, S. Imazu, M. Nakanishi, S. Nakagawa, T. mayumi, Biomedical Research Foundation, 1996.08

  • Special, Gene expression and nutrition:From cells to whole, 1996.04

Patents / Utility models / Designs 【 display / non-display

  • Europe, CELL PERMEABLE PEPTIDE, 1849798(Registration), 2006.02, 2014.10

  • United States, CELL PERMEABLE PEPTIDE, 7989588(Registration), 2006.02, 2011.08

  •  , PHYSIOLOGICALLY AKTIVE COMPLEX, 2003-200291(Registration), 2003.01

  • Korea Republic of, PHYSIOLOGICALLY ACTIVE COMPLEX, 韓国特願 10-2003-0004352(Registration), 2003.01

Awards 【 display / non-display

  • 2008 CRS Jorge Heller Journal of Controlled Release Best Paper Award, Shinsaku Nakagawa, Controlled Release Society, 2008.07

  • Zoological Science Awared, 1994.10

  • Zoological Science Awared, Shinsaku Nakagawa, Zoological Society of Japan, 1994.10